newsfilter
← Latest News
GlobeNewswire·

Mesoblast Announces Changes to Board of Directors' Leadership Roles

NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual